Merck & Co., Inc.
MRK
$79.29
$1.171.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.10% | 6.74% | 6.51% | 7.15% | 6.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.10% | 6.74% | 6.51% | 7.15% | 6.11% |
| Cost of Revenue | -5.08% | -7.65% | -7.37% | -3.09% | -2.07% |
| Gross Profit | 7.19% | 11.93% | 11.62% | 10.89% | 9.17% |
| SG&A Expenses | 3.54% | 2.20% | 2.15% | -0.84% | -0.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.56% | -6.67% | 20.78% | 14.57% | 14.03% |
| Operating Income | 27.39% | 42.34% | -18.71% | -6.56% | -9.11% |
| Income Before Tax | 415.96% | 955.37% | 84.21% | 181.83% | -74.34% |
| Income Tax Expenses | 70.94% | 85.38% | -44.92% | -34.50% | -27.33% |
| Earnings from Continuing Operations | 652.52% | 4,444.56% | 163.21% | 340.20% | -82.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -30.77% | -33.33% | -15.38% | -23.08% | 13.33% |
| Net Income | 656.03% | 4,589.59% | 163.63% | 341.53% | -82.30% |
| EBIT | 27.39% | 42.34% | -18.71% | -6.56% | -9.11% |
| EBITDA | 25.98% | 37.06% | -14.62% | -4.70% | -7.63% |
| EPS Basic | 654.34% | 4,574.05% | 163.70% | 340.50% | -82.24% |
| Normalized Basic EPS | 30.27% | 44.19% | -21.05% | -10.68% | -12.43% |
| EPS Diluted | 669.06% | 4,968.12% | 165.15% | 342.38% | -82.57% |
| Normalized Diluted EPS | 30.30% | 44.20% | -21.12% | -10.76% | -12.30% |
| Average Basic Shares Outstanding | -0.14% | -0.09% | -0.16% | -0.09% | 0.04% |
| Average Diluted Shares Outstanding | -0.09% | -0.03% | -0.22% | -0.13% | -0.19% |
| Dividend Per Share | 5.41% | 5.48% | 5.56% | 5.63% | 5.71% |
| Payout Ratio | -0.86% | -0.98% | -0.60% | -0.76% | 4.99% |